Market revenue in 2023 | USD 629.8 million |
Market revenue in 2030 | USD 1,060.3 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | Metered- dose inhalers (mdis) |
Fastest growing segment | Metered- dose inhalers (MDIs) |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Metered- dose inhalers (MDIs), Dry Powder Inhalers, Nebulizers |
Key market players worldwide | Lonza Group Ltd, Catalent Inc, Recipharm, Beximco Pharmaceuticals Ltd DR, Viatris Inc, Kindeva Drug Delivery, Quotient Sciences, Hovione, Colep Portugal |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to inhaled and intranasal products contract service providers market will help companies and investors design strategic landscapes.
Metered- dose inhalers (mdis) was the largest segment with a revenue share of 50.86% in 2023. Horizon Databook has segmented the North America inhaled and intranasal products contract service providers market based on metered- dose inhalers (mdis), dry powder inhalers, nebulizers covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America inhaled and intranasal products contract service providers market , including forecasts for subscribers. This continent databook contains high-level insights into North America inhaled and intranasal products contract service providers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account